Andrew Spokes latest buys and sells
20 reductions in Andrew Spokes's latest 13F filing, largest first. The largest is the reduction of TMO, $407.4M or 2.1% of the reported portfolio.
Key facts
- Reductions
- 20
- Largest move
- TMO, $407.4M
- Latest filing
- Nov 16, 2026
From Farallon Capital Management's filing for (Q3 2026), filed , against the filing for Jun 30, 2026.
| # | Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific IncTMO | ▼ Reduced 58% | −603.48K | $407.4M | 2.12% |
| 2 | Lantheus Holdings IncLNTH | ▼ Reduced 44% | −2.47M | $246.1M | 1.28% |
| 3 | Microsoft CorpMSFT | ▼ Reduced 34% | −379.25K | $194.5M | 1.01% |
| 4 | Tango Therapeutics IncTNGX | ▼ Reduced 63% | −7.73M | $192.7M | 1.00% |
| 5 | UnitedHealth Group IncUNH | ▼ Reduced 17% | −221.97K | $81.5M | 0.42% |
| 6 | Amazon.com IncAMZN | ▼ Reduced 10% | −264.63K | $65.9M | 0.34% |
| 7 | Aon PLCAON | ▼ Reduced 10% | −142.97K | $39.6M | 0.21% |
| 8 | Revolution Medicines IncRVMD | ▼ Reduced 1.0% | −131.44K | $27M | 0.14% |
| 9 | KKR & Co. IncKKR | ▼ Reduced 5.8% | −238.46K | $21.8M | 0.11% |
| 10 | AstraZeneca PLCAZN | ▼ Reduced 23% | −133.96K | $21.6M | 0.11% |
| 11 | Enanta Pharmaceuticals IncENTA | ▼ Reduced 61% | −1.47M | $19.3M | 0.10% |
| 12 | Novartis AGNVS | ▼ Reduced 30% | −107.99K | $15.4M | 0.08% |
| 13 | Grail IncGRAL | ▼ Reduced 2.2% | −92.39K | $12.9M | 0.07% |
| 14 | Guardant Health IncGH | ▼ Reduced 13% | −42.5K | $7.6M | 0.04% |
| 15 | Mobia Med IncMOBI | ▼ Reduced 61% | −690.6K | $6.5M | 0.03% |
| 16 | WabtecWAB | ▼ Reduced 1.9% | −16.64K | $4.8M | 0.02% |
| 17 | Sagimet Biosciences IncSGMT | ▼ Reduced 3.6% | −14.98K | $148K | 0.00% |
| 18 | Inflarx NVIFRX | ▼ Reduced 0.5% | −14.96K | $26.9K | 0.00% |
| 19 | Taysha Gene Therapies IncTSHA | ▼ Reduced 0.04% | −900 | $4.4K | 0.00% |
| 20 | Nvni Group Limitedno ticker on file | ▼ Reduced 12% | −43.61K | $750.2 | 0.00% |
Questions and answers
What did Andrew Spokes sell last quarter?
The largest sales in the latest 13F filing: TMO, $407.4M; LNTH, $246.1M; MSFT, $194.5M; TNGX, $192.7M; UNH, $81.5M; AMZN, $65.9M.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Andrew Spokes: buys and sells, Q3 2026 13F”, data as of 16 November 2026. https://funkfolio.com/gurus/activity?type=reduced&investor=farallon
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.